Anhui Kedgene Biotechnology Co.,Ltd

Esophageal Cancer, (NCT03081715)
Sponsors:
Hangzhou Cancer Hospital
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine